5-Bromo-N-isobutylfuran-2-carboxamide

Catalog No.: 
ACBEPD344
CAS No.: 
300381-28-6
Molecular Formula: 
C9H12BrNO2
Molecular Weight: 
246.10
5-Bromo-N-isobutylfuran-2-carboxamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$101.00InquiryInquiry
1g95%$222.00InquiryInquiry
5g95%$826.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Bromo-N-isobutylfuran-2-carboxamide
IUPAC Name5-bromo-N-isobutylfuran-2-carboxamide
MDL No.MFCD00498023
Molecular FormulaC9H12BrNO2
Molecular Weight246.10
SMILESO=C(C1=CC=C(Br)O1)NCC(C)C
InChI KeyIVIOHBAXQLCSFX-UHFFFAOYSA-N
Synonym5-bromo-N-isobutyl-2-furamide(SALTDATA: FREE);5-bromo-N-isobutyl-2-furamide;5-bromo-N-(2-methylpropyl)furan-2-carboxamide;2-Furancarboxamide, 5-bromo-N-(2-methylpropyl)-;5-Bromo-N-isobutylfuran-2-carboxamide
CAS No.300381-28-6

Synthetic Route by SureRoute

1. ACBEPD344 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLSKC139 route compound structure diagram
    ACLSKC13974098-36-5In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBEPD344 route product structure diagram
    ACBEPD344300381-28-6
Inquiry

2. ACBEPD344 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLSKC139 route compound structure diagram
    ACLSKC13974098-36-5In Stock
  2. Plus
  3. ACLNUT108 route compound structure diagram
    ACLNUT10826726-16-9In Stock
  4. Then
  5. ACBEPD344 route product structure diagram
    ACBEPD344300381-28-6
Inquiry

3. ACBEPD344 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLSKC139 route compound structure diagram
    ACLSKC13974098-36-5In Stock
  2. Plus
  3. ACDYZJ937 route compound structure diagram
    ACDYZJ9372527-99-3In Stock
  4. Then
  5. ACBEPD344 route product structure diagram
    ACBEPD344300381-28-6
Inquiry

Comments (0)